2156 related articles for article (PubMed ID: 8433013)
1. Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma.
Jimbow K; Iwashina T; Alena F; Yamada K; Pankovich J; Umemura T
J Invest Dermatol; 1993 Feb; 100(2 Suppl):231S-238S. PubMed ID: 8433013
[TBL] [Abstract][Full Text] [Related]
2. [Development of targeted chemoradiotherapy for malignant melanoma by exploitation of metabolic pathway].
Jimbow K
Hokkaido Igaku Zasshi; 1998 Mar; 73(2):105-10. PubMed ID: 9612704
[TBL] [Abstract][Full Text] [Related]
3. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
[TBL] [Abstract][Full Text] [Related]
4. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
Gili A; Thomas PD; Ota M; Jimbow K
Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
[TBL] [Abstract][Full Text] [Related]
5. [Utilization of melanin precursors for experimental chemotherapy of malignant melanoma].
Jimbow K; Miura S; Ito Y; Kasuga T; Ito S
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2125-32. PubMed ID: 6435538
[TBL] [Abstract][Full Text] [Related]
6. The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative.
Miura T; Jimbow K; Ito S
Int J Cancer; 1990 Nov; 46(5):931-4. PubMed ID: 2121652
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimelanoma activity of sterically congested tertiary amide analogues of N-acetyl-4-S-cysteaminylphenol.
Ferguson J; Rogers PM; Kelland LR; Robins DJ
Oncol Res; 2005; 15(2):87-94. PubMed ID: 16119006
[TBL] [Abstract][Full Text] [Related]
8. The great DOPA mystery: the source and significance of DOPA in phase I melanogenesis.
Riley PA
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):951-60. PubMed ID: 10643999
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes.
Ito S; Kato T; Ishikawa K; Kasuga T; Jimbow K
Biochem Pharmacol; 1987 Jun; 36(12):2007-11. PubMed ID: 3109434
[TBL] [Abstract][Full Text] [Related]
10. Phenolic melanin precursors provide a rational approach to the design of antitumor agents for melanoma.
Jimbow K; Miura T; Ito S; Ishikawa K
Pigment Cell Res; 1989; 2(1):34-9. PubMed ID: 2717528
[TBL] [Abstract][Full Text] [Related]
11. Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine.
Alena F; Iwashina T; Gili A; Jimbow K
Cancer Res; 1994 May; 54(10):2661-6. PubMed ID: 8168094
[TBL] [Abstract][Full Text] [Related]
12. Selective uptake of 2-thiouracil into melanin-producing systems depends on chemical binding to enzymically generated dopaquinone.
Palumbo A; d'Ischia M; Misuraca G; Iannone A; Prota G
Biochim Biophys Acta; 1990 Dec; 1036(3):221-7. PubMed ID: 2124140
[TBL] [Abstract][Full Text] [Related]
13. Selective in vivo and in vitro incorporation and accumulation of phenolic thioether amine into malignant melanoma and identification of a (58 kD) binding glycoprotein.
Yamada K; Jimbow K
Melanoma Res; 1992 Nov; 2(4):225-33. PubMed ID: 1490110
[TBL] [Abstract][Full Text] [Related]
14. Co-regulation of melanin precursors and tyrosinase in human pigment cells: roles of cysteine and glutathione.
Benathan M; Virador V; Furumura M; Kobayashi N; Panizzon RG; Hearing VJ
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):981-90. PubMed ID: 10644002
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimelanoma activity of reversed amide analogues of N-acetyl-4-S-cysteaminylphenol.
Nicoll K; Robertson J; Lant N; Kelland LR; Rogers PM; Robins DJ
Oncol Res; 2006; 16(2):97-106. PubMed ID: 16898270
[TBL] [Abstract][Full Text] [Related]
16. Melanin-related biochemistry of IGR 1 human melanoma cells.
Karg E; Odh G; Rosengren E; Wittbjer A; Rorsman H
Melanoma Res; 1991; 1(1):5-13. PubMed ID: 1822769
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and selective in vitro anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
Yukitake J; Otake H; Inoue S; Wakamatsu K; Olivares C; Solano F; Hasegawa K; Ito S
Melanoma Res; 2003 Dec; 13(6):603-9. PubMed ID: 14646624
[TBL] [Abstract][Full Text] [Related]
18. Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function.
Simon JD; Peles D; Wakamatsu K; Ito S
Pigment Cell Melanoma Res; 2009 Oct; 22(5):563-79. PubMed ID: 19627559
[TBL] [Abstract][Full Text] [Related]
19. Selective cytotoxicity of 4-S-cysteaminylphenol on follicular melanocytes of the black mouse: rational basis for its application to melanoma chemotherapy.
Ito Y; Jimbow K
Cancer Res; 1987 Jun; 47(12):3278-84. PubMed ID: 3107807
[TBL] [Abstract][Full Text] [Related]
20. Melanogenesis: a realistic target for antimelanoma therapy?
Riley PA
Eur J Cancer; 1991; 27(9):1172-7. PubMed ID: 1835632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
